简
繁
EN
简
繁
EN
Home
Latest
Finance
IPO
ETF
Technology
Overseas
Research
HOME
·
00874.HK
BAIYUNSHAN PH (00874.HK): Cefalexin Capsules Obtain Proprietary Medicine Registration Certificate from Macao Drug Administration
Tags：
BAIYUNSHAN PH
00874.HK
drug registration application
2026-07-20
BAIYUNSHAN PH (00874.HK): Dexamethasone Sodium Phosphate Injection (1ml:5mg) of Controlled Subsidiary Passes Generic Consistency Evaluation
Tags：
BAIYUNSHAN PH
00874.HK
NMPA Approval
2026-07-09
Baiyunshan(00874.HK): Cefaclor Sustained-release Tablets (II) of Its Branch Obtains Drug Registration Certificate
Tags：
Baiyunshan
00874.HK
Drug Registration Certificate
2026-06-10
BAIYUNSHAN PH(00874.HK): 2026 Q1 Report - Profit Attributable to Shareholders stood at CNY 1.78 billion, YoY decrease of 2.06%
Tags：
BAIYUNSHAN PH
00874.HK
financials
2026-04-27
Featured News
Finance
Xiabuxiabu (00520.HK): First-Half Loss Narrowed Significantly
Finance
JS Global Lifestyle (01691.HK): Expected Net Profit of No Less Than US$12 Million for First Half
Finance
REGENT PACIFIC GROUP (00575.HK): Expected to Swing to Profit in First Half
Finance
Sisram Medical Ltd (01696.HK): Expected First-Half Loss of US$900,000 to US$1.4 Million
Finance
APEX ACE HOLDING (06036.HK): Expected Interim Profit of HK$130 Million to HK$140 Million
Research
Autonomous Driving Concept Stocks Watch | BIDU-SW (09888.HK) strengthens in afternoon trading；The regulatory compliance framework for the robotaxi industry continues to improve
ETF
Hang Seng China Enterprises Index ETF (02828.HK) Gains 0.34% Intraday, Turnover Reaches HK$5.287 Billion
ETF
Tracker Fund Of Hong Kong (02800.HK) Rises 0.08% Intraday, Total Asset Size Hits HK$142.579 Billion
ETF
Premia China Treasury And Policy Bank Bond Long Duration Etf (02817.HK) Rises 0.30% Intraday, NAV Per Unit Stands at HK$150.715
ETF
Invesco Qqq Trust (03455.HK) Rises 0.28% Intraday with Average Trading Price of HK$5,444.598
Scan QR Code
Download App
